# Inpharma A.S.

- Location (FDA's records): Northborough, MA
- FDA decisions: 3 (1995–2003): 3 510(k) clearances
- Names in FDA's records: Inpharma A.S. (2); Inpharma (1)
- Product codes: LFD (2), LBH (1)
- Predicates its devices cite: 2 (1 its own); citations of its devices by later devices: 23 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Fresenius USA, Inc.: 1 (https://510kreport.com/company/fresenius-usa)

## Firms that cite its devices most
- Sinclair Pharmaceuticals, Ltd.: 2 (https://510kreport.com/company/sinclair-pharmaceuticals)
- Bartor Pharmacal Co., Inc.: 2 (https://510kreport.com/company/bartor-pharmacal)
- Eusa Pharma (Uk) Limited: 2 (https://510kreport.com/company/eusa-pharma-uk)
- Pulpdent Corp.: 2 (https://510kreport.com/company/pulpdent)
- Invado Pharmaceuticals: 2 (https://510kreport.com/company/invado-pharmaceuticals)
- Parnell Pharmaceuticals, Inc.: 1 (https://510kreport.com/company/parnell-pharmaceuticals)
- Pascal Co., Inc.: 1 (https://510kreport.com/company/pascal)
- Dentsply Intl.: 1 (https://510kreport.com/company/dentsply-intl)

## Its most-cited devices
- K945794: Duraphat (1995), cited by 8
- K991938: Caphosol Artificial Saliva (1999), cited by 8
- K030802: Caphosol (2003), cited by 7

## Recent decisions
- K030802: Caphosol (Nov 25, 2003)
- K991938: Caphosol Artificial Saliva (Aug 10, 1999)
- K945794: Duraphat (Jul 26, 1995)

Source page: https://510kreport.com/company/inpharma